ARMISTICE CAPITAL, LLC - Q1 2015 holdings

$226 Million is the total value of ARMISTICE CAPITAL, LLC's 27 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 96.6% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$30,965,000
+201.3%
150,000
+200.0%
13.72%
+177.9%
VNDA BuyVANDA PHARMACEUTICALS INC$21,241,000
+103.8%
2,284,000
+213.7%
9.41%
+87.9%
RXDX BuyIGNYTA INC$17,711,000
+70.9%
1,780,000
+17.6%
7.85%
+57.6%
SPPI BuySPECTRUM PHARMACEUTICALS INC$16,389,000
+15.3%
2,700,000
+31.6%
7.26%
+6.3%
KODK BuyEASTMAN KODAK CO$11,394,000
+11.7%
600,000
+27.7%
5.05%
+3.0%
BCOR NewBLUCORA INC$10,573,000774,000
+100.0%
4.69%
PBY BuyPEP BOYS MANNY MOE & JACK$10,486,000
+15.1%
1,090,000
+17.5%
4.65%
+6.1%
ATRS BuyANTARES PHARMA INC$10,298,000
+54.1%
3,800,000
+46.2%
4.56%
+42.1%
VCRA BuyVOCERA COMMUNICATIONS INC$8,988,000
+1.5%
906,000
+6.6%
3.98%
-6.4%
TBPH NewTHERAVANCE BIOPHARMA INC$8,883,000512,000
+100.0%
3.94%
WIFI BuyBOINGO WIRELESS INC$8,671,000
+5.7%
1,150,000
+7.5%
3.84%
-2.6%
APOL NewAPOLLO ED GROUP INCcl a$7,568,000400,000
+100.0%
3.35%
KZ BuyKONGZHONG CORPsponsored adr$6,913,000
+6.7%
1,250,000
+4.4%
3.06%
-1.5%
QLGC SellQLOGIC CORP$6,898,000
-19.3%
468,000
-27.1%
3.06%
-25.6%
PGNX NewPROGENICS PHARMACEUTICALS IN$6,865,0001,148,000
+100.0%
3.04%
SNAK NewINVENTURE FOODS INC$6,714,000600,000
+100.0%
2.98%
SNTA NewSYNTA PHARMACEUTICALS CORP$6,286,0003,240,000
+100.0%
2.79%
IAC SellIAC INTERACTIVECORP$6,072,000
-22.0%
90,000
-29.7%
2.69%
-28.0%
LL NewLUMBER LIQUIDATORS HLDGS INC$5,540,000180,000
+100.0%
2.46%
DMD NewDEMAND MEDIA INC$5,240,000916,000
+100.0%
2.32%
FHCO BuyFEMALE HEALTH CO$3,187,000
+20.6%
1,126,000
+67.1%
1.41%
+11.2%
NSPR NewINSPIREMD INC$2,240,0007,000,000
+100.0%
0.99%
OSTK NewOVERSTOCK COM INC DEL$1,720,00071,000
+100.0%
0.76%
RPTP SellRAPTOR PHARMACEUTICAL CORP$1,413,000
-83.2%
130,000
-83.8%
0.63%
-84.5%
IMUC NewIMMUNOCELLULAR THERAPEUTICS$1,199,0002,471,500
+100.0%
0.53%
IRGTQ NewIGNITE RESTAURANT GROUP INC$1,164,000240,000
+100.0%
0.52%
NERV NewMINERVA NEUROSCIENCES INC$1,013,000202,634
+100.0%
0.45%
RTRX ExitRETROPHIN INC$0-34,874
-100.0%
-0.20%
UNXLQ ExitUNI PIXEL INC$0-176,000
-100.0%
-0.48%
DRRX ExitDURECT CORP$0-3,849,266
-100.0%
-1.46%
ExitCENVEO CORPnote 7.000% 5/1$0-3,752
-100.0%
-1.79%
ExitEXELIXIS INCnote 4.250% 8/1$0-6,678
-100.0%
-1.82%
BSTC ExitBIOSPECIFICS TECHNOLOGIES CO$0-105,000
-100.0%
-1.95%
KND ExitKINDRED HEALTHCARE INC$0-234,000
-100.0%
-2.04%
UNTD ExitUNITED ONLINE INC$0-350,000
-100.0%
-2.45%
URBN ExitURBAN OUTFITTERS INC$0-172,000
-100.0%
-2.90%
LF ExitLEAPFROG ENTERPRISES INCcl a$0-1,500,000
-100.0%
-3.40%
TIME ExitTIME INC NEW$0-310,000
-100.0%
-3.67%
AEGR ExitAEGERION PHARMACEUTICALS INC$0-372,000
-100.0%
-3.74%
SODA ExitSODASTREAM INTERNATIONAL LTD$0-430,000
-100.0%
-4.16%
HPTX ExitHYPERION THERAPEUTICS INC$0-434,000
-100.0%
-5.00%
ZGNX ExitZOGENIX INC$0-9,400,000
-100.0%
-6.19%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings